Chapter/Section Purchase

1 Study Coverage
1.1 Activin Receptor Type 1 Product Introduction
1.2 Market by Type
1.2.1 Global Activin Receptor Type 1 Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 LJPC-6417
1.2.3 TP-0184
1.2.4 Dipyridamole
1.2.5 Others
1.3 Market by Application
1.3.1 Global Activin Receptor Type 1 Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Alport Syndrome
1.3.3 Chronic Kidney Disease
1.3.4 Kidney Fibrosis
1.3.5 Obesity
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Activin Receptor Type 1 Sales Estimates and Forecasts 2017-2028
2.2 Global Activin Receptor Type 1 Revenue Estimates and Forecasts 2017-2028
2.3 Global Activin Receptor Type 1 Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Activin Receptor Type 1 Sales by Region
2.4.1 Global Activin Receptor Type 1 Sales by Region (2017-2022)
2.4.2 Global Sales Activin Receptor Type 1 by Region (2023-2028)
2.5 Global Activin Receptor Type 1 Revenue by Region
2.5.1 Global Activin Receptor Type 1 Revenue by Region (2017-2022)
2.5.2 Global Activin Receptor Type 1 Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Activin Receptor Type 1 Sales by Manufacturers
3.1.1 Global Top Activin Receptor Type 1 Manufacturers by Sales (2017-2022)
3.1.2 Global Activin Receptor Type 1 Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Activin Receptor Type 1 in 2021
3.2 Global Activin Receptor Type 1 Revenue by Manufacturers
3.2.1 Global Activin Receptor Type 1 Revenue by Manufacturers (2017-2022)
3.2.2 Global Activin Receptor Type 1 Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Activin Receptor Type 1 Revenue in 2021
3.3 Global Activin Receptor Type 1 Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Activin Receptor Type 1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Activin Receptor Type 1 Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Activin Receptor Type 1 Sales by Type
4.1.1 Global Activin Receptor Type 1 Historical Sales by Type (2017-2022)
4.1.2 Global Activin Receptor Type 1 Forecasted Sales by Type (2023-2028)
4.1.3 Global Activin Receptor Type 1 Sales Market Share by Type (2017-2028)
4.2 Global Activin Receptor Type 1 Revenue by Type
4.2.1 Global Activin Receptor Type 1 Historical Revenue by Type (2017-2022)
4.2.2 Global Activin Receptor Type 1 Forecasted Revenue by Type (2023-2028)
4.2.3 Global Activin Receptor Type 1 Revenue Market Share by Type (2017-2028)
4.3 Global Activin Receptor Type 1 Price by Type
4.3.1 Global Activin Receptor Type 1 Price by Type (2017-2022)
4.3.2 Global Activin Receptor Type 1 Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Activin Receptor Type 1 Sales by Application
5.1.1 Global Activin Receptor Type 1 Historical Sales by Application (2017-2022)
5.1.2 Global Activin Receptor Type 1 Forecasted Sales by Application (2023-2028)
5.1.3 Global Activin Receptor Type 1 Sales Market Share by Application (2017-2028)
5.2 Global Activin Receptor Type 1 Revenue by Application
5.2.1 Global Activin Receptor Type 1 Historical Revenue by Application (2017-2022)
5.2.2 Global Activin Receptor Type 1 Forecasted Revenue by Application (2023-2028)
5.2.3 Global Activin Receptor Type 1 Revenue Market Share by Application (2017-2028)
5.3 Global Activin Receptor Type 1 Price by Application
5.3.1 Global Activin Receptor Type 1 Price by Application (2017-2022)
5.3.2 Global Activin Receptor Type 1 Price Forecast by Application (2023-2028)
6 North America
6.1 North America Activin Receptor Type 1 Market Size by Type
6.1.1 North America Activin Receptor Type 1 Sales by Type (2017-2028)
6.1.2 North America Activin Receptor Type 1 Revenue by Type (2017-2028)
6.2 North America Activin Receptor Type 1 Market Size by Application
6.2.1 North America Activin Receptor Type 1 Sales by Application (2017-2028)
6.2.2 North America Activin Receptor Type 1 Revenue by Application (2017-2028)
6.3 North America Activin Receptor Type 1 Market Size by Country
6.3.1 North America Activin Receptor Type 1 Sales by Country (2017-2028)
6.3.2 North America Activin Receptor Type 1 Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Activin Receptor Type 1 Market Size by Type
7.1.1 Europe Activin Receptor Type 1 Sales by Type (2017-2028)
7.1.2 Europe Activin Receptor Type 1 Revenue by Type (2017-2028)
7.2 Europe Activin Receptor Type 1 Market Size by Application
7.2.1 Europe Activin Receptor Type 1 Sales by Application (2017-2028)
7.2.2 Europe Activin Receptor Type 1 Revenue by Application (2017-2028)
7.3 Europe Activin Receptor Type 1 Market Size by Country
7.3.1 Europe Activin Receptor Type 1 Sales by Country (2017-2028)
7.3.2 Europe Activin Receptor Type 1 Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Activin Receptor Type 1 Market Size by Type
8.1.1 Asia Pacific Activin Receptor Type 1 Sales by Type (2017-2028)
8.1.2 Asia Pacific Activin Receptor Type 1 Revenue by Type (2017-2028)
8.2 Asia Pacific Activin Receptor Type 1 Market Size by Application
8.2.1 Asia Pacific Activin Receptor Type 1 Sales by Application (2017-2028)
8.2.2 Asia Pacific Activin Receptor Type 1 Revenue by Application (2017-2028)
8.3 Asia Pacific Activin Receptor Type 1 Market Size by Region
8.3.1 Asia Pacific Activin Receptor Type 1 Sales by Region (2017-2028)
8.3.2 Asia Pacific Activin Receptor Type 1 Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Activin Receptor Type 1 Market Size by Type
9.1.1 Latin America Activin Receptor Type 1 Sales by Type (2017-2028)
9.1.2 Latin America Activin Receptor Type 1 Revenue by Type (2017-2028)
9.2 Latin America Activin Receptor Type 1 Market Size by Application
9.2.1 Latin America Activin Receptor Type 1 Sales by Application (2017-2028)
9.2.2 Latin America Activin Receptor Type 1 Revenue by Application (2017-2028)
9.3 Latin America Activin Receptor Type 1 Market Size by Country
9.3.1 Latin America Activin Receptor Type 1 Sales by Country (2017-2028)
9.3.2 Latin America Activin Receptor Type 1 Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Activin Receptor Type 1 Market Size by Type
10.1.1 Middle East and Africa Activin Receptor Type 1 Sales by Type (2017-2028)
10.1.2 Middle East and Africa Activin Receptor Type 1 Revenue by Type (2017-2028)
10.2 Middle East and Africa Activin Receptor Type 1 Market Size by Application
10.2.1 Middle East and Africa Activin Receptor Type 1 Sales by Application (2017-2028)
10.2.2 Middle East and Africa Activin Receptor Type 1 Revenue by Application (2017-2028)
10.3 Middle East and Africa Activin Receptor Type 1 Market Size by Country
10.3.1 Middle East and Africa Activin Receptor Type 1 Sales by Country (2017-2028)
10.3.2 Middle East and Africa Activin Receptor Type 1 Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Blueprint Medicines Corp
11.1.1 Blueprint Medicines Corp Corporation Information
11.1.2 Blueprint Medicines Corp Overview
11.1.3 Blueprint Medicines Corp Activin Receptor Type 1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Blueprint Medicines Corp Activin Receptor Type 1 Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Blueprint Medicines Corp Recent Developments
11.2 Daiichi Sankyo Company Ltd
11.2.1 Daiichi Sankyo Company Ltd Corporation Information
11.2.2 Daiichi Sankyo Company Ltd Overview
11.2.3 Daiichi Sankyo Company Ltd Activin Receptor Type 1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Daiichi Sankyo Company Ltd Activin Receptor Type 1 Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Daiichi Sankyo Company Ltd Recent Developments
11.3 La Jolla Pharmaceutical Company
11.3.1 La Jolla Pharmaceutical Company Corporation Information
11.3.2 La Jolla Pharmaceutical Company Overview
11.3.3 La Jolla Pharmaceutical Company Activin Receptor Type 1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 La Jolla Pharmaceutical Company Activin Receptor Type 1 Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 La Jolla Pharmaceutical Company Recent Developments
11.4 Oncodesign SA
11.4.1 Oncodesign SA Corporation Information
11.4.2 Oncodesign SA Overview
11.4.3 Oncodesign SA Activin Receptor Type 1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Oncodesign SA Activin Receptor Type 1 Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Oncodesign SA Recent Developments
11.5 Tolero Pharmaceuticals Inc
11.5.1 Tolero Pharmaceuticals Inc Corporation Information
11.5.2 Tolero Pharmaceuticals Inc Overview
11.5.3 Tolero Pharmaceuticals Inc Activin Receptor Type 1 Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Tolero Pharmaceuticals Inc Activin Receptor Type 1 Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Tolero Pharmaceuticals Inc Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Activin Receptor Type 1 Industry Chain Analysis
12.2 Activin Receptor Type 1 Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Activin Receptor Type 1 Production Mode & Process
12.4 Activin Receptor Type 1 Sales and Marketing
12.4.1 Activin Receptor Type 1 Sales Channels
12.4.2 Activin Receptor Type 1 Distributors
12.5 Activin Receptor Type 1 Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Activin Receptor Type 1 Industry Trends
13.2 Activin Receptor Type 1 Market Drivers
13.3 Activin Receptor Type 1 Market Challenges
13.4 Activin Receptor Type 1 Market Restraints
14 Key Findings in The Global Activin Receptor Type 1 Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer